Marla Cunningham

Author

Marla Cunningham
Marla Cunningham is the Executive Director of ISAPP. She brings over 20 years of experience in the probiotic, prebiotic, and natural products industry, working across innovation, clinical research, product development, regulatory compliance, and education. She trained as a healthcare practitioner in complementary medicine and has written and presented extensively for clinical audiences on the implementation of biotic-related science.

Articles written by Marla Cunningham

1-4 of 4 articles

  • Microbiome endpoints in clinical trials for biotics – where do we stand and what have we learnt?
    I’m sure you’ve read the results of trials similar to these (fictional) conclusions: ‘Our findings showed an increase in Faecalibacterium and Enterococcus, two…
    Read more

  • Expert Panel at ISAPP Annual Meeting Addresses Probiotic Use for Premature Infants
    The use of probiotics in premature infants has been highly topical in recent months. Probiotic use for the prevention of…
    Read more

  • Do new product formats need new clinical trials?
    By Marla Cunningham​, Metagenics Global R&D Innovation Manager and 2021 ISAPP Industry Advisory Committee representative Let’s assume a hypothetical clinical…
    Read more

  • Five things scientists should know about the future of probiotics and prebiotics
    As anyone connected with probiotics and prebiotics knows – there’s a lot happening in this space. After a well-attended discussion…
    Read more